Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why

Zomedica Corp. (NYSEAMERICAN:ZOM)’s share price fell 2.8% on Wednesday . The stock traded as low as $0.12 and last traded at $0.12. 5,779,875 shares changed hands during mid-day trading, an increase of 20% from the average session volume of 4,808,725 shares. The stock had previously closed at $0.12.

Wall Street Analysts Forecast Growth

Separately, Noble Financial upgraded Zomedica to a “strong-buy” rating in a report on Monday, November 11th.

Zomedica Stock Performance

The company has a market capitalization of $115.63 million, a PE ratio of -1.97 and a beta of 1.04.

Hedge Funds Weigh In On Zomedica

An institutional investor recently bought a new position in Zomedica stock. Jane Street Group LLC acquired a new stake in Zomedica Corp. (NYSEAMERICAN:ZOM) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 179,074 shares of the company’s stock, valued at approximately $25,000. 8.95% of the stock is currently owned by institutional investors and hedge funds.

Zomedica Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.